[ Price : $8.95]
AstraZeneca submits a supplemental NDA for Nexium, seeking approval for short-term (up to 6 weeks) treatment of gastroesophageal r...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance on evaluating cardiovascular risk in new antidiabetic therapies.[ Price : $8.95]
Federal Register Notice: FDA seeks comments on the Emergency Shortages Data Collection System.[ Price : $8.95]
Federal Register Notice: FDA seeks comments on FDAs medical device recall authority.[ Price : $8.95]
Federal Register Notice: FDA determines that 11 drug products were not withdrawn from sale for reasons of safety or effectiveness.[ Price : $8.95]
ViroPharma says FDA and HHS have not responded to its requests for the administrative record on Vancocin bioequivalence and it is ...[ Price : $8.95]
Industry-connected health and disease advocacy organizations call for an FDA commissioner who is science-driven and can bring vari...[ Price : $8.95]
Federal Register Notice: FDAs Office of Orphan Product Development provides notice of a funding opportunity announcement for feder...